IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers?

Eissmann, Moritz F; Buchert, Michael; Ernst, Matthias

Eissmann, Moritz F; Buchert, Michael; Ernst, Matthias.

Afiliação

Eissmann MF; Olivia Newton-John Cancer Research Institute, and La Trobe University School of Cancer Medicine, Heidelberg, VIC, Australia.
Buchert M; Olivia Newton-John Cancer Research Institute, and La Trobe University School of Cancer Medicine, Heidelberg, VIC, Australia.
Ernst M; Olivia Newton-John Cancer Research Institute, and La Trobe University School of Cancer Medicine, Heidelberg, VIC, Australia.

Front Immunol ; 11: 1389, 2020.

Article em En | MEDLINE | ID: mdl-32719677

Assuntos

Neoplasias Gastrointestinais/imunologia; Interleucina-33/imunologia; Mastócitos/imunologia; Microambiente Tumoral/imunologia; Animais; Humanos

Palavras-chave

ST2; cytokine signaling; gastrointestinal (GI) malignancies; innate immunity; interleukin 33 (IL33); mast cell (MC); therapy targets; tumor microenvironment (TME)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Microambiente Tumoral / Interleucina-33 / Neoplasias Gastrointestinais / Mastócitos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google